About Densitas
Densitas is a global leader in artificial intelligence solutions for breast cancer screening and mammography quality improvement. The company's flagship intelliMammo platform delivers comprehensive AI-powered tools that address the most pressing challenges facing breast imaging providers today. The platform automates mammography positioning assessment, breast density evaluation, MQSA EQUIP compliance reporting, equipment quality control, and continuing education tracking. By streamlining routine tasks and providing actionable analytics, Densitas enables technologists and radiologists to focus on complex cases while reducing burnout and improving operational efficiency. The intelliMammo platform provides standardized, reproducible breast density assessments aligned with ACR 5th edition guidance, automated positioning quality review with advanced analytics for benchmarking and trend detection, and comprehensive quality metrics that support real-time technique coaching. Densitas serves health systems, imaging centers, and radiology practices globally, with solutions trusted by leading healthcare organizations. The company's evidence-based approach combines rigorous scientific validation across multi-site, multi-vendor datasets with real-world clinical usability. Through strategic partnerships with major imaging technology providers and integration into existing PACS and workflow systems, Densitas delivers vendor-neutral solutions that fit seamlessly into clinical operations while elevating mammography quality standards and patient care outcomes.
Mission & Story
Mission
Creating a world where cancer can't hide by providing clinically proven AI-powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes
Clinical Focus
Medical conditions and clinical areas addressed by Densitas.
Who It Serves
Milestones & Awards
Recent Milestones
ACR Learning Network Vendor Partner designation (October 2025); Mount Sinai ACR ImPower collaboration results published (October 2025); MAMMO.IQ multicenter study results published in Journal of Breast Imaging (July 2025); TungstenQI strategic partnership launched (April 2025)
Awards & Recognition
ACR Learning Network Vendor Partner designation; Featured in peer-reviewed publications
Key Partnerships
Social & Media
Latest Updates
Densitas Debuts intelliRisk, a High-Risk Breast Cancer Patient Management Platform
Densitas Announces the Commercial Release of intelliMaven™: The First GPT AI Companion to Elevate Mammography Quality Standards.
Densitas: AI Identifies Persistent Mammography Positioning Challenges Impacting Screening Quality and Cancer Detection
Densitas Announces the Commercial Availability of intelliRisk, a High-Risk Breast Cancer Patient Management Platform
Densitas / ACR Learning Network Strategic Collaboration to Improve Mammography Positioning
Company Details
- Headquarters
- Halifax, NS, Canada
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.